Genes related to inflammation

Genes related to inflammation encompass a broad and heterogeneous category of genomic sequences that encode proteins essential for the body's response to tissue injury, pathogens, and irritants. This group includes pro-inflammatory cytokines (such as TNF, IL1B, and IL6), chemokines, enzymes (such as PTGS2/COX-2), and key transcription factors like NF-kappaB that regulate the expression of inflammatory mediators [Source: NIH, PubMed]. While the acute inflammatory response is a vital protective mechanism, chronic activation of these genes is a central driver in the pathogenesis of numerous conditions, including rheumatoid arthritis, inflammatory bowel disease, and atherosclerosis [Source: Nature Reviews Immunology]. In the context of drug discovery, this term is considered too broad to be a single therapeutic target; instead, specific proteins encoded by these genes, such as TNF-alpha or JAK kinases, are the actual targets for pharmacological intervention. Therapeutic strategies often involve monoclonal antibodies to neutralize circulating cytokines or small molecules to inhibit intracellular signaling pathways that promote the inflammatory phenotype [Source: PMC].

Other names

Inflammatory genesPro-inflammatory genesInflammatory mediatorsInflammation-associated genes

Drugs targeting these gene products work through various mechanisms including TNF-alpha inhibition, cyclooxygenase (COX) inhibition, Janus kinase (JAK) inhibition, and glucocorticoid receptor agonism to suppress the inflammatory cascade [Source: StatPearls, NCBI].